Cerebral small-vessel disease at high altitude: A comparison of patients from plateau and plain

被引:1
|
作者
Shu, Junlong [1 ,2 ]
Fei, Wen [3 ]
Zhang, Jing [1 ]
Li, Fan [1 ]
Hao, Yu [3 ]
Ding, Zhijie [3 ]
Ji, Shiyong [3 ]
Zhao, Weiwei [3 ]
Hu, Yaxiong [3 ]
Sun, Wei [1 ]
Huang, Yining [1 ,2 ]
Zhao, Yuhua [3 ]
Zhang, Wei [1 ,2 ]
机构
[1] Peking Univ First Hosp, Dept Neurol, Beijing, Peoples R China
[2] Beijing Key Lab Neurovasc Dis Discovery, Beijing, Peoples R China
[3] Peoples Hosp Tibet Autonomous Reg, Dept Neurol, Lhasa, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2023年 / 14卷
关键词
cerebral small-vessel disease; white matter hyperintensity; plateau; plain; stroke; lacune of presumed vascular origin; WHITE-MATTER HYPERINTENSITIES; OBSTRUCTIVE SLEEP-APNEA; PARTIAL-PRESSURE; STROKE; OXYGEN; TIBET; MRI;
D O I
10.3389/fneur.2023.1086476
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purposeCerebral small-vessel disease (CSVD) is prevalent worldwide and one of the major causes of stroke and dementia. For patients with CSVD at high altitude, a special environmental status, limited information is known about their clinical phenotype and specific neuroimaging change. We investigated the clinical and neuroimaging features of patients residing at high altitude by comparing with those in the plain, trying to explore the impact of high altitude environment on CSVD. MethodsTwo cohorts of CSVD patients from the Tibet Autonomous Region and Beijing were recruited retrospectively. In addition to the collection of clinical diagnoses, demographic information and traditional vascular risk factors, the presence, location, and severity of lacunes and white matter hyperintensities were assessed by manual counting and using age-related white matter changes (ARWMC) rating scale. Differences between the two groups and influence of long-term residing in the plateau were analyzed. ResultsA total of 169 patients in Tibet (high altitude) and 310 patients in Beijing (low altitude) were enrolled. Fewer patients in high altitude group were found with acute cerebrovascular events and concomitant traditional vascular risk factors. The median (quartiles) ARWMC score was 10 (4, 15) in high altitude group and 6 (3, 12) in low altitude group. Less lacunes were detected in high altitude group [0 (0, 4)] than in low altitude group [2 (0, 5)]. In both groups, most lesions located in the subcortical (especially frontal) and basal ganglia regions. Logistic regressions showed that age, hypertension, family history of stroke, and plateau resident were independently associated with severe white matter hyperintensities, while plateau resident was negatively correlated with lacunes. ConclusionPatients of CSVD residing at high altitude showed more severe WMH but less acute cerebrovascular events and lacunes in neuroimaging, comparing to patients residing at low altitude. Our findings suggest potential biphasic effect of high altitude on the occurrence and progression of CSVD.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Cerebral Venous Thrombosis at High Altitude: A Comparison of Patients From Plateau and Plain in China
    Sha, Yuhui
    Ci, Yang
    Cidan, Zhuoga
    Zhao, Yuhua
    Zhou, Lixin
    Ni, Jun
    STROKE, 2024, 55
  • [2] Fiber Connectivity Density in Cerebral Small-Vessel Disease Patients With Mild Cognitive Impairment and Cerebral Small-Vessel Disease Patients With Normal Cognition
    Liu, Chengxia
    Shi, Lin
    Zhu, Wenhao
    Yang, Shiqi
    Sun, Pan
    Qin, Yuanyuan
    Tang, Xiangyu
    Zhang, Shun
    Yao, Yihao
    Wang, Zhenxiong
    Zhu, Wenzhen
    Wang, Defeng
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [3] Hyperlipidemia and cerebral small-vessel disease
    Jessica R. L. Warsch
    Clinton B. Wright
    Nature Reviews Neurology, 2010, 6 : 307 - 308
  • [4] The integrity of dynamic cerebral autoregulation in patients with small-vessel disease
    Bims, JM
    Markus, HS
    Kalra, L
    STROKE, 2005, 36 (02) : 517 - 517
  • [5] Emerging insights from the genetics of cerebral small-vessel disease
    Rutten-Jacobs, Loes C. A.
    Rost, Natalia S.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1471 (01) : 5 - 17
  • [6] STROKE Hyperlipidemia and cerebral small-vessel disease
    Warsch, Jessica R. L.
    Wright, Clinton B.
    NATURE REVIEWS NEUROLOGY, 2010, 6 (06) : 307 - 308
  • [7] Large-vessel correlates of cerebral small-vessel disease
    Brisset, Marion
    Boutouyrie, Pierre
    Pico, Fernando
    Zhu, Yicheng
    Zureik, Mahmoud
    Schilling, Sabrina
    Dufouil, Carole
    Mazoyer, Bernard
    Laurent, Stephane
    Tzourio, Christophe
    Debette, Stephanie
    NEUROLOGY, 2013, 80 (07) : 662 - 669
  • [8] C-reactive protein and cerebral small-vessel disease - An opportunity to reassess small-vessel disease physiopathology?
    Di Napoli, M
    Papa, F
    CIRCULATION, 2005, 112 (06) : 781 - 785
  • [9] CSF Biomarkers and Neuropsychological Profiles in Patients with Cerebral Small-Vessel Disease
    Hermann, Peter
    Romero, Carlos
    Schmidt, Christian
    Reis, Clemens
    Zerr, Inga
    PLOS ONE, 2014, 9 (08):
  • [10] NO SIGNS OF CEREBRAL SMALL-VESSEL DISEASE ON TRANSCRANIAL DOPPLER IN MIGRAINE PATIENTS
    Larrosa, D.
    Ramon, C.
    Riesco, N.
    Cernuda, E.
    Martinez-Camblor, P.
    Pascual, J.
    CEPHALALGIA, 2016, 36 : 125 - 126